Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled Clinical Study to Explore the Mechanism of Action (MOA) of ON101 Cream in Patients With Diabetic Foot Ulcers (DFUs).
Conditions
Interventions
ON101 Cream
Placebo
Locations
1
Taiwan
Kueiho Chen
Taipei, Taiwan
Start Date
February 23, 2021
Primary Completion Date
November 9, 2021
Completion Date
December 24, 2021
Last Updated
January 5, 2023
NCT07198061
NCT07193992
NCT06873646
NCT06747377
NCT05747872
NCT02844660
Lead Sponsor
Oneness Biotech Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions